In Medicare Part D, generic drug coverage was cost saving compared with no coverage in bipolar disorder and schizophrenia while improving health outcomes.
Bruce L. Rollman, MD, MPH
Advertisement
Articles by Bruce L. Rollman, MD, MPH
Advertisement
Latest Updated Articles
- Cost-Effectiveness of Medicare Drug Plans in Schizophrenia and Bipolar Disorder
Published: February 11th 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
4
Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology
5
